The news about David Cameron’s prostate cancer hit me with a thud of recognition: the hesitation, the domestic nudge, the reluctant appointment, the quietly mounting dread. His wife told him to get ...

Former President Joe Biden and other older men may not be getting routine prostate cancer screenings but his recent Stage 4 diagnosis raises questions about whether that's always the best choice.

An informational website and a mobile testing van in Philadelphia are making it easier to learn about cancer and get tested. Hall of Fame running back Emmitt Smith will be hosting a series of short ...

Former President Biden has been diagnosed with an aggressive form of prostate cancer. Among men in the U.S., prostate cancer is the most common cancer and the second leading cause of cancer deaths.

Bob Lane stresses the importance of open discussions about prostate cancer and early screening to overcome stigma and improve outcomes. Men often avoid discussing prostate cancer due to concerns about ...

Health professionals are using former President Joe Biden’s recent cancer diagnosis as an opportunity to raise awareness of the need for screening and early detection. Biden, 82, has been diagnosed ...

Men's breast cancer awareness is crucial as it often goes unrecognized, leading to advanced stages at diagnosis, Michael Hassett, MD, explains.

WESTLAKE, Ohio — Like a lot of kids growing up, Ben Lavelle tried his hand at many sports, but his foot, led the way. "I'd always been like pretty good at kicking a ball from kickball recess and it ...

People with localized prostate cancer treated according to guidelines developed by an international panel of doctors are more likely to die of something other than the disease, new research shows. A ...

Men account for about 1% of breast cancer cases, but that still represents thousands of lives every year, and many go undiagnosed. In early 2025, Nashville’s own Peter Cornell, musician and brother to ...

GG1 prostate cancer can have heterogeneous outcomes, with some patients having intermediate- or high-risk disease, challenging the notion of GG1 as uniformly low-risk. Removing the cancer label for ...